Hence, in breast cancer, compared with other neoplasms, PD-L1 expression levels are relatively low (about 15–30% of cases) [7], and lymphocyte infiltration in most breast tumors is modest [6, 9]. This evidence concerns the gene CD274 and breast carcinoma.